MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001185/mwtabprimaryOK200Mass SpectrometryESIFatty Liver Diseasehttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001185Source:Healthy Control Liver TissueSource:Negative Control Empty ScaffoldSource:NASH Liver Tissue from PatientSource:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1LiverReversed phase POSITIVE ION MODE. Reversed phase NEGATIVE ION MODE. Reversed phase UNSPECIFIED ION MODE.MetabolomicsWorkbenchMetabolomicsHomo SapiensUniversity of PittsburghGlutamic acidHexoseSerinePyruvic acidLeucineItaconic acidFructose-1,6-biphosphateHistidineArginineAspartic acidTyrosineCreatinineAdenosineAlaninePhosphoenolpyruvic acidMethionineOxoglutaric acidTryptophanCAR(2:0)Glucose-6-phosphateCitric acidFumaric acidValineLysineSuccinic acidCis-Aconitic acidLactic acidOrnithineGlutamineSteatohepatitides, fatty change of liver, AA673258, Sir2alpha, Liver, human being, Man (Taxonomy), Visceral, Liver Steatoses, fatty liver, Fatty infiltration of liver, Liver Steatosis, Modern, familial, Tissue, Sir2, Fatty liver, sirtuin, Steatohepatitis, SIR2L1, Steatosis of Liver, steatosis of liver, human, genetic, Human, sir2l1, Steatoses, Visceral Steatoses, Sir2a, Homo sapiens, Silent Mating Type Information Regulation 2 Homolog 1., Visceral Steatosis, Modern Man, Steatosis, inherited genetic, hepatic lipidosis, simple tissue, Fatty, constitutitional genetic, hereditary, Sirt1, Man, Liver steatosisiones., backward, Ionen, ion, Ion, ions, reversedfalseGenetic and metabolic characterization of bioengineered human fatty liver tissue with modified SIRT1 expressionST0011859606